Lisata Therapeutics, Inc.
LSTA
$1.09
-$0.04-3.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 100.00K | -- | 70.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 100.00K | -- | 70.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | 100.00K | -- | 70.00K |
| SG&A Expenses | 3.41M | 3.74M | 2.05M | 2.46M | 2.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.99M | 4.94M | 3.18M | 4.41M | 4.94M |
| Operating Income | -3.99M | -4.94M | -3.08M | -4.41M | -4.87M |
| Income Before Tax | -2.93M | -4.88M | -2.95M | -4.25M | -4.66M |
| Income Tax Expenses | -- | -387.00K | 0.00 | -- | -- |
| Earnings from Continuing Operations | -2.93M | -4.49M | -2.95M | -4.25M | -4.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.93M | -4.49M | -2.95M | -4.25M | -4.66M |
| EBIT | -3.99M | -4.94M | -3.08M | -4.41M | -4.87M |
| EBITDA | -3.99M | -4.94M | -3.06M | -4.37M | -4.82M |
| EPS Basic | -0.32 | -0.50 | -0.34 | -0.49 | -0.54 |
| Normalized Basic EPS | -0.20 | -0.34 | -0.21 | -0.30 | -0.34 |
| EPS Diluted | -0.32 | -0.50 | -0.34 | -0.49 | -0.54 |
| Normalized Diluted EPS | -0.20 | -0.34 | -0.21 | -0.30 | -0.34 |
| Average Basic Shares Outstanding | 9.11M | 9.01M | 8.80M | 8.74M | 8.61M |
| Average Diluted Shares Outstanding | 9.11M | 9.01M | 8.80M | 8.74M | 8.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |